1-4 of 4
Ido Paz-Priel, M.D.
Close
Sort by
Journal Articles

Canonical NF-κB Signalling Is a Potential Target in FLT3/ITD AML.

Jing Zhang, PhD, Li Li, PhD, Alan D. Friedman, M.D., Donald Small, MD, PhD, Ido Paz-Priel, M.D.
Journal: Blood
Blood (2012) 120 (21): 2447.
https://doi.org/10.1182/blood.V120.21.2447.2447
Published: 2012
Journal Articles

C/EBPα, C/EBPα Oncoproteins, or C/EBPβ Preferentially Bind NF-κB p50 Compared with p65 Via Conserved Residues In the C/EBP Basic Region

Julia E. Dooher, Ph.D., Ido Paz-Priel, M.D., Simone Houng, Albert S. Baldwin, Jr., Ph.D., Alan D. Friedman, M.D.
Journal: Blood
Blood (2010) 116 (21): 708.
https://doi.org/10.1182/blood.V116.21.708.708
Published: 2010
Journal Articles

NF-κB Target Genes Activation Via Displacement of HDACs Bound to NF-κB p50 Homodimers by C/EBPα, Its AML Oncoproteins or C/EBPβ.

Ido Paz-Priel, M.D., Simone Houng, M.Eng., Julia E. Dooher, Ph.D., Alan D. Friedman, M.D.
Journal: Blood
Blood (2010) 116 (21): 3637.
https://doi.org/10.1182/blood.V116.21.3637.3637
Published: 2010
Journal Articles

C/EBPα and C/EBPα Myeloid Oncoproteins Inhibit Apoptosis and Induce Bcl-2 Via DNA-Binding Dependent and Independent Mechanisms.

Ido Paz-Priel, M.D., Dong Hong Cai, M.D., Ph.D., Dehua Wang, M.D., M.S., Caroline A. Heckman, Ph.D., Adrian F. Gombart, Ph.D., H. Phillip Koeffler, M.D., Linda M. Boxer, M.D., Ph.D., Alan D. Friedman, M.D.
Journal: Blood
Blood (2004) 104 (11): 2561.
https://doi.org/10.1182/blood.V104.11.2561.2561
Published: 2004